» Articles » PMID: 17015635

Rescue of TRAF3-null Mice by P100 NF-kappa B Deficiency

Overview
Journal J Exp Med
Date 2006 Oct 4
PMID 17015635
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Proper activation of nuclear factor (NF)-kappaB transcription factors is critical in regulating fundamental biological processes such as cell survival and proliferation, as well as in inflammatory and immune responses. Recently, the NF-kappaB signaling pathways have been categorized into the canonical pathway, which results in the nuclear translocation of NF-kappaB complexes containing p50, and the noncanonical pathway, which involves the induced processing of p100 to p52 and the formation of NF-kappaB complexes containing p52 (Bonizzi, G., and M. Karin. 2004. Trends Immunol. 25:280-288). We demonstrate that loss of tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) results in constitutive noncanonical NF-kappaB activity. Importantly, TRAF3-/- B cells show ligand-independent up-regulation of intracellular adhesion molecule 1 and protection from spontaneous apoptosis during in vitro culture. In addition, we demonstrate that loss of TRAF3 results in profound accumulation of NF-kappaB-inducing kinase in TRAF3-/- cells. Finally, we show that the early postnatal lethality observed in TRAF3-deficient mice is rescued by compound loss of the noncanonical NF-kappaB p100 gene. Thus, these genetic data clearly demonstrate that TRAF3 is a critical negative modulator of the noncanonical NF-kappaB pathway and that constitutive activation of the noncanonical NF-kappaB pathway causes the lethal phenotype of TRAF3-deficient mice.

Citing Articles

PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer.

Jung D, Seo M, Jo J, Kim K, Kim C, Kang H NPJ Precis Oncol. 2024; 8(1):170.

PMID: 39090283 PMC: 11294552. DOI: 10.1038/s41698-024-00654-2.


Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.

Wang P, Liu Z, Sweef O, Saeed A, Kluz T, Costa M Cancer Lett. 2024; 589:216827.

PMID: 38527692 PMC: 11375691. DOI: 10.1016/j.canlet.2024.216827.


A review of the literature on the use of CRISPR/Cas9 gene therapy to treat hepatocellular carcinoma.

Amjad E, Pezzani R, Sokouti B Oncol Res. 2024; 32(3):439-461.

PMID: 38361756 PMC: 10865741. DOI: 10.32604/or.2023.044473.


Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3.

Cai M, Peng H, Liu M, Huang M, Zheng W, Zhang G Int J Nanomedicine. 2023; 18:7065-7077.

PMID: 38046234 PMC: 10693246. DOI: 10.2147/IJN.S438229.


Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.

Boyce B, Li J, Yao Z, Xing L Endocrinol Metab (Seoul). 2023; 38(5):504-521.

PMID: 37749800 PMC: 10613774. DOI: 10.3803/EnM.2023.501.


References
1.
Mackay F, Woodcock S, Lawton P, Ambrose C, Baetscher M, Schneider P . Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999; 190(11):1697-710. PMC: 2195729. DOI: 10.1084/jem.190.11.1697. View

2.
Qing G, Qu Z, Xiao G . Stabilization of basally translated NF-kappaB-inducing kinase (NIK) protein functions as a molecular switch of processing of NF-kappaB2 p100. J Biol Chem. 2005; 280(49):40578-82. DOI: 10.1074/jbc.M508776200. View

3.
Deng L, Wang C, Spencer E, Yang L, Braun A, You J . Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 2000; 103(2):351-61. DOI: 10.1016/s0092-8674(00)00126-4. View

4.
Xiao G, Harhaj E, Sun S . NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell. 2001; 7(2):401-9. DOI: 10.1016/s1097-2765(01)00187-3. View

5.
Claudio E, Brown K, Park S, Wang H, Siebenlist U . BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol. 2002; 3(10):958-65. DOI: 10.1038/ni842. View